Verve Therapeutics, Inc.
Clinical trials sponsored by Verve Therapeutics, Inc., explained in plain language.
-
One-Shot gene therapy aims to permanently lower bad cholesterol
Disease control Recruiting nowThis early-stage study is testing the safety of a single dose of an experimental gene-editing treatment called VERVE-102. It is designed for people with inherited high cholesterol or early heart disease who need to lower their 'bad' LDL cholesterol further. The treatment aims to …
Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
One-Shot gene therapy aims to permanently lower heart disease risk
Disease control Recruiting nowThis early-stage study is testing the safety of a new, one-time gene-editing treatment called VERVE-201. It is designed for people with dangerously high cholesterol and triglycerides that don't respond well to standard medications. The treatment works by editing a gene in the liv…
Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC